CUSIP 09061G101COMBMRNQ4 2025
39 filings · latest Jan 21, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 19.14M | $1.14B |
| 2 | Vanguard Group Inc | 18.13M | $1.08B |
| 3 | Dodge & Cox | 14.57M | $866.04M |
| 4 | Primecap Management Co/Ca/ | 14.55M | $864.67M |
| 5 | Norges Bank | 7.53M | $447.57M |
| 6 | State Street Corp | 7.52M | $447.10M |
| 7 | Aqr Capital Management LLC | 6.69M | $395.20M |
| 8 | Viking Global Investors LP | 6.04M | $358.78M |
| 9 | Geode Capital Management, LLC |
| 4 | Aug 14, 2025 | Viking Global Investors LP | 13G/A | 6.4% | 12.29M | SEC |
| 5 | May 13, 2025 | Capital Research Global Investors | 13G/A | 4.8% | 9.15M | SEC |
| 6 | Apr 29, 2025 | Blackrock, Inc. | 13G/A | 10.8% | 20.62M | SEC |
| 7 | Feb 13, 2025 | Capital Research Global Investors | 13G/A | 6.8% | 12.99M | SEC |
| 8 | Sep 30, 2024 | Viking Global Investors LP | 13G | 5.1% | 9.75M | SEC |
| 9 | Jul 10, 2024 | Vanguard Group Inc | 13G/A | 10.0% | 18.99M | SEC |
| 10 | Jul 8, 2024 | Blackrock Inc. | 13G/A | 12.0% | 22.78M | SEC |
See the full Schedule 13D/13G history for Biomarin Pharmaceutical Inc.
Unlock full history| 3.67M |
| $218.39M |
| 10 | Dimensional Fund Advisors LP | 3.32M | $197.40M |